Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079301 | SCV000111171 | benign | not specified | 2014-03-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000200821 | SCV000252725 | benign | Long QT syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000251201 | SCV000317405 | benign | Cardiovascular phenotype | 2015-06-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000079301 | SCV000740554 | likely benign | not specified | 2017-05-18 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001647053 | SCV001156904 | benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001647053 | SCV001857511 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000079301 | SCV001951547 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000079301 | SCV001978781 | benign | not specified | no assertion criteria provided | clinical testing |